“The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Morning Overview on MSN
A drug could become the first approved treatment for the muscle disease dermatomyositis
Adults living with dermatomyositis, a rare inflammatory disease that attacks muscles and skin, could soon have access to the ...
Gammagard Liquid is a brand-name infusion prescribed for certain rare immune conditions. Gammagard Liquid contains the active ingredient immune globulin (human). Gammagard Liquid has boxed warnings. A ...
MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and ...
ARLINGTON, Texas--(BUSINESS WIRE)--AOM Infusion (“AOM”), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by Kedrion Biopharma as a ...
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
Intravenous immunoglobulin (IVIG) is donor-derived antibodies used in myasthenia gravis (MG) for fast symptom control. It’s used for flares, maintenance, bridging slower therapies, or pre-surgery ...
There is a push to reduce the demand for the plasma-derived therapy, as patients, physicians and governments worry about ...
Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.
The prescribed dosage for Hizentra (immune globulin subcutaneous [human]) may vary depending on an individual’s treatment plan. Other factors, including your specific diagnosis, body weight, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results